JPS6218547B2 - - Google Patents
Info
- Publication number
- JPS6218547B2 JPS6218547B2 JP52058569A JP5856977A JPS6218547B2 JP S6218547 B2 JPS6218547 B2 JP S6218547B2 JP 52058569 A JP52058569 A JP 52058569A JP 5856977 A JP5856977 A JP 5856977A JP S6218547 B2 JPS6218547 B2 JP S6218547B2
- Authority
- JP
- Japan
- Prior art keywords
- methoxyethyl
- phenoxy
- formula
- hydroxy
- propyl ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl Chemical group 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 4
- MELFVOGWPJFQBB-UHFFFAOYSA-N 3-[4-(2-methoxyethyl)phenoxy]propane-1,2-diol Chemical compound COCCC1=CC=C(OCC(O)CO)C=C1 MELFVOGWPJFQBB-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 3
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 150000003513 tertiary aromatic amines Chemical class 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI761404A FI56964C (fi) | 1976-05-19 | 1976-05-19 | 2-hydroxi-3-(4-(2-metoxietyl)fenoxi)-propylestrar som aer mellanprodukter vid framstaellning av 1-(4-(2-metoxietyl)-fenoxi)-3-((1-metyletyl)amino)-2-propanol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS52142033A JPS52142033A (en) | 1977-11-26 |
| JPS6218547B2 true JPS6218547B2 (US06312121-20011106-C00033.png) | 1987-04-23 |
Family
ID=8510004
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5856977A Granted JPS52142033A (en) | 1976-05-19 | 1977-05-19 | Substituted phenoxy propanol derivatives and process for preparing same |
| JP61031744A Pending JPS6229424B1 (US06312121-20011106-C00033.png) | 1976-05-19 | 1986-02-14 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61031744A Pending JPS6229424B1 (US06312121-20011106-C00033.png) | 1976-05-19 | 1986-02-14 |
Country Status (4)
| Country | Link |
|---|---|
| JP (2) | JPS52142033A (US06312121-20011106-C00033.png) |
| FI (1) | FI56964C (US06312121-20011106-C00033.png) |
| PL (1) | PL109679B1 (US06312121-20011106-C00033.png) |
| SE (2) | SE432927B (US06312121-20011106-C00033.png) |
-
1976
- 1976-05-19 FI FI761404A patent/FI56964C/fi not_active IP Right Cessation
-
1977
- 1977-02-04 PL PL1977195814A patent/PL109679B1/pl unknown
- 1977-05-03 SE SE7705119A patent/SE432927B/xx not_active IP Right Cessation
- 1977-05-19 JP JP5856977A patent/JPS52142033A/ja active Granted
-
1983
- 1983-12-23 SE SE8307159A patent/SE8307159D0/xx not_active Application Discontinuation
-
1986
- 1986-02-14 JP JP61031744A patent/JPS6229424B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SE8307159L (sv) | 1983-12-23 |
| FI56964C (fi) | 1980-05-12 |
| JPS6229424B1 (US06312121-20011106-C00033.png) | 1987-06-25 |
| SE8307159D0 (sv) | 1983-12-23 |
| FI56964B (fi) | 1980-01-31 |
| SE432927B (sv) | 1984-04-30 |
| JPS52142033A (en) | 1977-11-26 |
| PL109679B1 (en) | 1980-06-30 |
| PL195814A1 (pl) | 1978-02-13 |
| FI761404A (US06312121-20011106-C00033.png) | 1977-11-20 |
| SE7705119L (sv) | 1977-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU867298A3 (ru) | Способ получени производных пиперидина или их солей | |
| JPS61207369A (ja) | ３つの置換基を有する安息香酸中間体 | |
| RU2272036C2 (ru) | Способ получения мезилатов производных пиперазина | |
| US4681944A (en) | Process for preparing certain 1-lower alkanoyl or benzoyl-4-(lower alkanoyl or benzoyl-methylidene)-1,4-dihydropyridines or acid addition salts thereof | |
| JPS6218547B2 (US06312121-20011106-C00033.png) | ||
| JP2771994B2 (ja) | プロペン酸誘導体の製造法 | |
| US3911008A (en) | Polar-substituted propanolamines as anti-angina and anti-hypertensive agents | |
| US4927968A (en) | Chemical intermediates and process | |
| SU507241A3 (ru) | Способ получени производных теофиллина | |
| IL93393A (en) | Process for the preparation of -0-carboxypyridyl and 0-carboxyquinolylimidazolinones | |
| JP2527961B2 (ja) | 安息香酸エステル誘導体及びその製造方法 | |
| JPS6242902B2 (US06312121-20011106-C00033.png) | ||
| SU549078A3 (ru) | Способ получени производных 1фенокси-3-амино-пропан-2-ола или их солей | |
| SU457211A3 (ru) | Способ получени производных 1-фенокси -3-аминопропан-2-ола | |
| JP2627238B2 (ja) | マロン酸ジアミド化合物の製造方法 | |
| JPS61189231A (ja) | ４，４′−ジアミノジフエニルエタン誘導体の製造法 | |
| JPS5929578B2 (ja) | 置換フエノキシ脂肪酸類を製造する方法 | |
| JP3770678B2 (ja) | 光学活性アルコール及びそのカルボン酸エステル | |
| SU552901A3 (ru) | Способ получени производных 1-(3-арилокси-2-оксипропил)-пиперидинов или их солей | |
| JPH0148267B2 (US06312121-20011106-C00033.png) | ||
| DE1770802A1 (de) | Indolyl-(3)-acetonitrile und Verfahren zu ihrer Herstellung | |
| SU527136A3 (ru) | Способ получени пиридохинолиновых эфиров | |
| KR880002619B1 (ko) | 메토프로롤의 제조방법 | |
| SU365889A1 (ru) | Способ получения 2 | |
| JPS62207237A (ja) | β−アルコキシアクロレイン誘導体の製造法 |
